Your partner in DMPK and in Agrosciences
Growing complexity, longer timelines, quality and confidentiality issues, high personnel turnover, continuous searching for expertise along with low costs: these are some of the most daunting pre-clinical and clinical research challenges you face today when outsourcing your priority studies. Eurofins ADME BIOANALYSES is a GLP compliant CRO founded in 1987. In recognition of the challenges you face, we offer you our expertise in the fields of pharmacokinetics, metabolism, bioanalysis and residue analysis.
A proven quality of services
Since the establishment of Eurofins ADME BIOANALYSES, we have been successfully inspected every 2 years by AFSSAPS[1].
Due to our expertise and comprehensive range of services which are compliant with EMEA and FDA regulatory requirements[2], we are well positioned to be your professional and valued partner.
The quality and reliability of our performance is best reflected by the numerous ongoing and long-lasting collaborations we maintain with leading international companies.
[1] AFSSAPS: Agence Française de Sécurité Sanitaire des Produits de Santé (French Agency for Health Products Safety)
[2] Successful FDA General Facility inspection July 2009
News
Eurofins ADME BIOANALYSES set up a team specialised on DBS method validations using low sampling volumes to fit with paediatric development and 3R (Reduction, Refinement, Replacement). Using an API5500 QTrap, we are able to reach low sensitivity.